BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 10383892)

  • 1. cDNA cloning, expression and activity of a second human aflatoxin B1-metabolizing member of the aldo-keto reductase superfamily, AKR7A3.
    Knight LP; Primiano T; Groopman JD; Kensler TW; Sutter TR
    Carcinogenesis; 1999 Jul; 20(7):1215-23. PubMed ID: 10383892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An ethoxyquin-inducible aldehyde reductase from rat liver that metabolizes aflatoxin B1 defines a subfamily of aldo-keto reductases.
    Ellis EM; Judah DJ; Neal GE; Hayes JD
    Proc Natl Acad Sci U S A; 1993 Nov; 90(21):10350-4. PubMed ID: 8234296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protection against aflatoxin B1-induced cytotoxicity by expression of the cloned aflatoxin B1-aldehyde reductases rat AKR7A1 and human AKR7A3.
    Bodreddigari S; Jones LK; Egner PA; Groopman JD; Sutter CH; Roebuck BD; Guengerich FP; Kensler TW; Sutter TR
    Chem Res Toxicol; 2008 May; 21(5):1134-42. PubMed ID: 18416522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular cloning, expression and catalytic activity of a human AKR7 member of the aldo-keto reductase superfamily: evidence that the major 2-carboxybenzaldehyde reductase from human liver is a homologue of rat aflatoxin B1-aldehyde reductase.
    Ireland LS; Harrison DJ; Neal GE; Hayes JD
    Biochem J; 1998 May; 332 ( Pt 1)(Pt 1):21-34. PubMed ID: 9576847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resistance to aflatoxin B1 is associated with the expression of a novel aldo-keto reductase which has catalytic activity towards a cytotoxic aldehyde-containing metabolite of the toxin.
    Hayes JD; Judah DJ; Neal GE
    Cancer Res; 1993 Sep; 53(17):3887-94. PubMed ID: 8395332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduction of aflatoxin B1 dialdehyde by rat and human aldo-keto reductases.
    Guengerich FP; Cai H; McMahon M; Hayes JD; Sutter TR; Groopman JD; Deng Z; Harris TM
    Chem Res Toxicol; 2001 Jun; 14(6):727-37. PubMed ID: 11409944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Major differences exist in the function and tissue-specific expression of human aflatoxin B1 aldehyde reductase and the principal human aldo-keto reductase AKR1 family members.
    O'connor T; Ireland LS; Harrison DJ; Hayes JD
    Biochem J; 1999 Oct; 343 Pt 2(Pt 2):487-504. PubMed ID: 10510318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aldo-keto reductase-7A protects liver cells and tissues from acetaminophen-induced oxidative stress and hepatotoxicity.
    Ahmed MM; Wang T; Luo Y; Ye S; Wu Q; Guo Z; Roebuck BD; Sutter TR; Yang JY
    Hepatology; 2011 Oct; 54(4):1322-32. PubMed ID: 21688283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transgenic expression of aflatoxin aldehyde reductase (AKR7A1) modulates aflatoxin B1 metabolism but not hepatic carcinogenesis in the rat.
    Roebuck BD; Johnson DN; Sutter CH; Egner PA; Scholl PF; Friesen MD; Baumgartner KJ; Ware NM; Bodreddigari S; Groopman JD; Kensler TW; Sutter TR
    Toxicol Sci; 2009 May; 109(1):41-9. PubMed ID: 19168568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aldo-keto reductases 7A subfamily: A mini review.
    Zhao M; Chen J; Chen H; Zhang J; Li D
    Chem Biol Interact; 2024 Mar; 391():110896. PubMed ID: 38301882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Androgen-regulated expression of a novel member of the aldo-keto reductase superfamily in regrowing rat prostate.
    Nishi N; Shoji H; Miyanaka H; Nakamura T
    Endocrinology; 2000 Sep; 141(9):3194-9. PubMed ID: 10965890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemoprevention of aflatoxin B1 hepatocarcinogenesis by coumarin, a natural benzopyrone that is a potent inducer of aflatoxin B1-aldehyde reductase, the glutathione S-transferase A5 and P1 subunits, and NAD(P)H:quinone oxidoreductase in rat liver.
    Kelly VP; Ellis EM; Manson MM; Chanas SA; Moffat GJ; McLeod R; Judah DJ; Neal GE; Hayes JD
    Cancer Res; 2000 Feb; 60(4):957-69. PubMed ID: 10706111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical features of aflatoxin B1-exposed patients with liver cancer and the molecular mechanism of aflatoxin B1 on liver cancer cells.
    Zhou R; Liu M; Liang X; Su M; Li R
    Environ Toxicol Pharmacol; 2019 Oct; 71():103225. PubMed ID: 31376682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protection conferred by selenium deficiency against aflatoxin B1 in the rat is associated with the hepatic expression of an aldo-keto reductase and a glutathione S-transferase subunit that metabolize the mycotoxin.
    McLeod R; Ellis EM; Arthur JR; Neal GE; Judah DJ; Manson MM; Hayes JD
    Cancer Res; 1997 Oct; 57(19):4257-66. PubMed ID: 9331086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterisation of a novel mouse liver aldo-keto reductase AKR7A5.
    Hinshelwood A; McGarvie G; Ellis E
    FEBS Lett; 2002 Jul; 523(1-3):213-8. PubMed ID: 12123834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aldo-Keto Reductases as Early Biomarkers of Hepatocellular Carcinoma: A Comparison Between Animal Models and Human HCC.
    Torres-Mena JE; Salazar-Villegas KN; Sánchez-Rodríguez R; López-Gabiño B; Del Pozo-Yauner L; Arellanes-Robledo J; Villa-Treviño S; Gutiérrez-Nava MA; Pérez-Carreón JI
    Dig Dis Sci; 2018 Apr; 63(4):934-944. PubMed ID: 29383608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization and Analysis of Mammalian AKR7A Gene Promoters: Implications for Transcriptional Regulation.
    Rajib SA; Sharif Siam MK
    Biochem Genet; 2020 Feb; 58(1):171-188. PubMed ID: 31529389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantification of urinary aflatoxin B1 dialdehyde metabolites formed by aflatoxin aldehyde reductase using isotope dilution tandem mass spectrometry.
    Johnson DN; Egner PA; Obrian G; Glassbrook N; Roebuck BD; Sutter TR; Payne GA; Kensler TW; Groopman JD
    Chem Res Toxicol; 2008 Mar; 21(3):752-60. PubMed ID: 18266327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of glutathione S-transferases and aldehyde reductase by chemoprotectors: studies of mechanisms responsible for inducible resistance to aflatoxin B1.
    Hayes JD; McLeod R; Ellis EM; Pulford DJ; Ireland LS; McLellan LI; Judah DJ; Manson MM; Neal GE
    IARC Sci Publ; 1996; (139):175-87. PubMed ID: 8923030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel homodimeric and heterodimeric rat gamma-hydroxybutyrate synthases that associate with the Golgi apparatus define a distinct subclass of aldo-keto reductase 7 family proteins.
    Kelly VP; Sherratt PJ; Crouch DH; Hayes JD
    Biochem J; 2002 Sep; 366(Pt 3):847-61. PubMed ID: 12071861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.